Integrated systems modeling of severe asthma: Exploration of IL-33/ST2 antagonism.
Saved in:
| Title: | Integrated systems modeling of severe asthma: Exploration of IL-33/ST2 antagonism. |
|---|---|
| Authors: | Gadkar K; Genentech, Inc., South San Francisco, California, USA.; Denali Therapeutics, Inc., South San Francisco, California, USA., Feigelman J; Genentech, Inc., South San Francisco, California, USA., Sukumaran S; Genentech, Inc., South San Francisco, California, USA.; Janssen, Inc., Spring House, Pennsylvania, USA., Rodrigo MC; Genentech, Inc., South San Francisco, California, USA.; Stryker, Inc., Fremont, California, USA., Staton T; Genentech, Inc., South San Francisco, California, USA., Cai F; Genentech, Inc., South San Francisco, California, USA.; AbbVie, Inc., South San Francisco, California, USA., Bauer RN; Genentech, Inc., South San Francisco, California, USA., Choy DF; Genentech, Inc., South San Francisco, California, USA., Stokes CL; Stokes Consulting, Redwood City, California, USA., Scheerens H; Genentech, Inc., South San Francisco, California, USA., Ramanujan S; Genentech, Inc., South San Francisco, California, USA. |
| Source: | CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2022 Sep; Vol. 11 (9), pp. 1268-1277. Date of Electronic Publication: 2022 Jul 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2163-8306 |
|---|---|
| DOI: | 10.1002/psp4.12842 |
